Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation

• Amanda L. Sharpe ,

  Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: sharpe@uiwtx.edu

  Affiliations Department of Pharmaceutical Sciences, Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas, United States of America, Department of Cellular and Integrative Physiology, UT Health, San Antonio, Texas, United States of America

  http://orcid.org/0000-0002-8717-4067

  ⨯
• Erika Varela,

  Roles Investigation, Validation

  Affiliation Department of Cellular and Integrative Physiology, UT Health, San Antonio, Texas, United States of America

  ⨯
• Michael J. Beckstead

  Roles Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliations Department of Cellular and Integrative Physiology, UT Health, San Antonio, Texas, United States of America, Center for Biomedical Neuroscience, UT Health, San Antonio, Texas, United States of America

  ⨯